Medicines and Healthcare products Regulatory Agency (MHRA)
We are seeking views on a proposal to make Acnecide Face 5% w/w Gel and Acnecide Face Wash 5% w/w Gel available from general sales outlets.
This consultation seeks your views on how the Medicines and Healthcare products Regulatory Agency’s (MHRA) legislation and regulatory processes would have to be modified in the event of the UK not securing a deal with the EU after the UK’s exit, with no Implementation Period. This consultation covers no-deal proposals on medicines, clinical trials and medical devices.
This consultation invites views on the proposed steps we intend to take to make sure the UK meets its obligations to transpose the 'safety features' provisions of the Falsified Medicines Directive (FMD).
We are considering making Colourstart Test 65mcg Cutaneous Patch available to buy without prescription from retail outlets. We always want to involve the public and healthcare professionals in decisions that affect them. We want to know what you think about this change.
Command paper responding to the Health and Social Care Committee's report 'Brexit: medicines, medical devices and substances of human origin'.
MHRA is developing guidance for health institutions wishing to apply the exemption to the new in vitro diagnostic medical device regulation (2017/746) and the new medical device regulation (2017/745).
We are reviewing the impact of the Human Medicines Regulations 2012 (‘the 2012 Regulations’).
We are considering making Sildenafil 50mg film-coated tablets available to buy from pharmacies.
We are developing a strategy for the creation of pharmacopoeial public quality standards for biological medicines.
We are considering making Dovonex Psoriasis 50 microgram/g Ointment available to buy from pharmacies.
We are considering making Arthriex 750mg and 1500mg film-coated tablets available to buy from pharmacies.
We want to know what you think about our proposal to Nasonex Allergy Control Nasal Spray available without prescription.
MHRA is asking for feedback on proposals to change the legal classification of Otrivine extra dual relief nasal spray solution from prescription only medicine (POM) to pharmacy only (P).
We are considering making Maloff Protect anti-malaria tablets available to buy from pharmacies.
We are seeking views on amending fees for the regulation of medical devices.
MHRA helps Queen’s University Belfast bring innovation and regulation together
Seeks views on proposed changes to the Human Medicines Regulations and the Medicines Act.
MHRA is asking for feedback on proposals to introduce proportionate fees for getting a notification from MHRA to put an e-cigarette on the market in the UK.
Describes the working relationship between the Department of Health and Medicines and Healthcare products Regulatory Agency (MHRA).
MHRA is asking for feedback on proposals to change the legal classification of Ibuprofen Seven Plus 200mg/5ml Oral Suspension
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.